NCT06368986View on ClinicalTrials.gov

A Study to Investigate the Effect of Food on the Bioavailability of a Capsid Inhibitor (CAI) in Male and Female Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

April 17, 2024

Primary Completion Date

October 2, 2024

Study Completion Date

October 2, 2024

Conditions

HIV Infections

Interventions

DRUG

VH4011499 Dose A

VH4011499 administered in fasted or fed conditions.

DRUG

VH4011499 Dose B

VH4011499 Dose B administered in fasted or fed conditions.

Trial Locations (1)

78744 -1645

GSK Investigational Site, Austin

Sponsors

Lead Sponsor

ViiV Healthcare

All Listed Sponsors

lead

ViiV Healthcare

INDUSTRY

NCT06368986 - A Study to Investigate the Effect of Food on the Bioavailability of a Capsid Inhibitor (CAI) in Male and Female Healthy Participants | Biotech Hunter | Biotech Hunter